Correlation Between Opioid Drug Prescription and Opioid-Related Mortality in Spain as a Surveillance Tool: Ecological Study

Background Opioid drug prescription (ODP) and opioid-related mortality (ORM) have increased in Spain. However, their relationship is complex, as ORM is registered without considering the type of opioid (legal or illegal). Objective This ecological study aimed to examine the correlation between ODP and ORM in Spain and discuss their usefulness as a surveillance tool. Methods This was an ecological descriptive study using retrospective annual data (2000-2019) from the Spanish general population. Data were collected from people of all ages. Information on ODP was obtained from the Spanish Medicines Agency in daily doses per 1000 inhabitants per day (DHD) for total ODP, total ODP excluding those with better safety protocols (codeine and tramadol), and each opioid drug separately. Rates of ORM (per 1,000,000 inhabitants) were calculated based on deaths registered (International Classification of Diseases, 10th Revision codes) as opioid poisoning by the National Statistics Institute, derived from the drug data recorded by medical examiners in death certificates. Opioid-related deaths were considered to be those that indicated opioid consumption (accidental, infringed, or self-inflicted) as the main cause of death: death due to accidental poisoning (X40-X44), intentional self-inflicted poisoning (X60-X64), drug-induced aggression (X85), and poisoning of undetermined intention (Y10-Y14). A descriptive analysis was carried out, and correlations between the annual rates of ORM and DHD of the prescribed opioid drugs globally, excluding medications of the least potential risk of overdose and lowest treatment tier, were analyzed using Pearson linear correlation coefficient. Their temporal evolution was analyzed using cross-correlations with 24 lags and the cross-correlation function. The analyses were carried out using Stata and StatGraphics Centurion 19. Results The rate of ORM (2000-2019) ranged between 14 and 23 deaths per 1,000,000 inhabitants, with a minimum in 2006 and an increasing trend starting in 2010. The ODP ranged between 1.51 to 19.94 DHD. The rates of ORM were directly correlated with the DHD of total ODP (r=0.597; P=.006), total ODP without codeine and tramadol (r=0.934; P<.001), and every prescribed opioid except buprenorphine (P=.47). In the time analysis, correlations between DHD and ORM were observed in the same year, although not statistically significant (all P≥.05). Conclusions There is a correlation between greater availability of prescribed opioid drugs and an increase in opioid-related deaths. The correlation between ODP and ORM may be a useful tool in monitoring legal opiates and possible disturbances in the illegal market. The role of tramadol (an easily prescribed opioid) is important in this correlation, as is that of fentanyl (the strongest opioid). Measures stronger than recommendations need to be taken to reduce off-label prescribing. This study shows that not only is opioid use directly related to the prescribing of opioid drugs above what is desirable but also an increase in deaths.

[1]  A. Gual,et al.  Systematic review on the clinical management of chronic pain and comorbid opioid use disorder. , 2022, Adicciones.

[2]  K. Venner,et al.  Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study , 2022, BMJ Open.

[3]  Ariadna Angulo-Brunet,et al.  Estimating the Prevalence of Recreational Opioid Use in Spain Using a Multiplier Method , 2022, International journal of environmental research and public health.

[4]  Michael A. Smith,et al.  Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review , 2022, Pharmacotherapy.

[5]  A. Oliva,et al.  Opioid use trends in Spain: the case of the island of La Gomera (2016–2019) , 2021, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  M. Martín-Pérez,et al.  Prevalence of Clinical Factors before Inflammatory Bowel Disease Diagnosis among 380,000 Girls Scheduled for Papillomavirus Vaccination: A Cohort Study , 2021 .

[7]  J. Aronson,et al.  Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories , 2021, British journal of pain.

[8]  T. Gomes,et al.  Measuring the Burden of Opioid-Related Mortality in Ontario, Canada, During the COVID-19 Pandemic , 2021, JAMA network open.

[9]  E. Buchser,et al.  European clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain , 2021, European journal of pain.

[10]  P. Jannetto The North American Opioid Epidemic. , 2020, Therapeutic drug monitoring.

[11]  S. Peiró,et al.  Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study , 2020, Frontiers in Pharmacology.

[12]  V. Paudyal,et al.  Causes, Nature and Toxicology of Fentanyl-Associated Deaths: A Systematic Review of Deaths Reported in Peer-Reviewed Literature , 2020, Journal of pain research.

[13]  L. Degenhardt,et al.  All-Cause and Overdose Mortality Risk Among People Prescribed Opioids: A Systematic Review and Meta-analysis. , 2020, Pain medicine.

[14]  D. González-Bermejo,et al.  Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication , 2020, Pharmacoepidemiology and drug safety.

[15]  S. Reines,et al.  Misuse of Tramadol in the United States: An Analysis of the National Survey of Drug Use and Health 2002-2017 , 2020, Substance abuse : research and treatment.

[16]  A. Rahimi-Movaghar,et al.  Tramadol use and public health consequences in Iran: a systematic review and meta-analysis. , 2020, Addiction.

[17]  Andrew J Boslett,et al.  Using contributing causes of death improves prediction of opioid involvement in unclassified drug overdoses in US death records. , 2020, Addiction.

[18]  J. A. Moral-Muñoz,et al.  The evolution of opioid-related mortality and potential years of life lost in Spain from 2008 to 2017: differences between Spain and the United States , 2020, Current medical research and opinion.

[19]  P. Kurdyak,et al.  Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007–2016 , 2019, BMC Health Services Research.

[20]  A. Alonso-Babarro,et al.  Opioid consumption in the Community of Madrid (Spain) between 2004 and 2014 , 2019, Revista Clínica Española (English Edition).

[21]  K. Bibeau,et al.  Tramadol Prescription over a 4-Year Period in the USA , 2019, Current Pain and Headache Reports.

[22]  C. Bosetti,et al.  Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990–2016 , 2018, European journal of pain.

[23]  Tara Gomes,et al.  The Burden of Opioid-Related Mortality in the United States , 2018, JAMA network open.

[24]  Z. Haklai,et al.  Fatal Overdoses of Opioids in Israel 2005–2014 , 2017, European Addiction Research.

[25]  N. Claes,et al.  Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: A systematic review , 2017, The European journal of general practice.

[26]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[27]  I. Scott,et al.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis , 2014, BMJ Open.

[28]  L. Leresche,et al.  Age and gender trends in long-term opioid analgesic use for noncancer pain. , 2010, American journal of public health.

[29]  A. Carvajal,et al.  Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine , 2008, European Journal of Clinical Pharmacology.

[30]  Ioannis N. Evaggelidis,et al.  Correlation of Opioid Mortality with Prescriptions and Social Determinants: A Cross-sectional Study of Medicare Enrollees , 2017, Drugs.

[31]  C. Teljeur,et al.  Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. , 2014, British journal of clinical pharmacology.